Valore202020212022202320242025TTMSpese di vendita, generali e amministrative1.73 B1.95 B2 B2.02 B2.23 B2.22 B2.22 BRicerca e sviluppo———————Reddito operativo2.45 B3.26 B1.77 B725.6 M1.09 B1.38 B1.38 BProventi non operativi, Totale-226.3 M52.6 M-16.5 M44.1 M82.3 M-40 M-40 MOneri finanziari, al netto degli interessi capitalizzati207.4 M212.1 M180.3 M199.6 M208.3 M224.1 M224.1 MProventi non operativi, esclusi gli oneri finanziari-401.6 M-202 M-171.5 M-171 M-186.2 M-209.1 M-209.1 MEntrate/uscite straordinarie-32.1 M42.5 M-25.3 M15.5 M60.2 M-55 M-55 MUtile al lordo delle imposte2.22 B3.15 B1.59 B567.5 M958.1 M1.09 B9.64 BQuota di utile2.9 M26.5 M5.4 M-1.4 M-1.4 M-13.3 M-13.3 MImposte662.1 M747.1 M302 M188.5 M212.4 M229.8 M229.8 MInteressi di minoranza900 K2.2 M1.5 M1.2 M1.1 M1.2 M1.2 MAltri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate1.56 B2.38 B1.28 B379.2 M746 M876.5 M876.5 MAttività cessate———38.8 M00—Utile netto1.56 B2.38 B1.28 B418 M746 M876.5 M876.5 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari1.56 B2.38 B1.28 B418 M746 M876.5 M876.5 MUtile base per azione (EPS base)13.7421.1312.074.88.8910.5410.54Utile diluito per azione (EPS diluito)13.6420.95124.778.8410.4610.46Numero medio di azioni ordinarie in circolazione113.26 M112.56 M106.04 M87.1 M83.9 M83.2 M333.3 MAzioni diluite in circolazione114.07 M113.49 M106.62 M87.6 M84.4 M83.8 M335.7 MEBITDA3 B3.95 B2.35 B1.28 B1.71 B2.14 B1.98 BEBIT2.37 B3.21 B1.72 B705.6 M1.07 B1.46 B1.3 BCosto del fatturato9.03 B10.5 B10.49 B8.8 B9.38 B9.94 B9.94 BAltri costi del venduto———————Ammortamento e svalutazione (liquidità)624.7 M745.1 M633.9 M577.3 M643.5 M681.1 M681.1 M
Labcorp Holdings Inc
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.